Global Medication Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 110272
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Medication market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Medication market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Medication global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Brand Drugs segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Medication include Pfizer, Roche, Sanofi, Johnson & Johnson, and Merck & Co. (MSD), etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Medication market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Brand Drugs

Generic Drug

Market segment by Application, can be divided into

Hospital

Clinic

Other

Market segment by players, this report covers

Pfizer

Roche

Sanofi

Johnson & Johnson

Merck & Co. (MSD)

Novartis

AbbVie

Gilead Sciences

GlaxoSmithKline (GSK)

Amgen

AstraZeneca

Bristol-Myers Squibb

Eli Lilly

Teva

Bayer

Novo Nordisk

Allergan

Takeda

Boehringer Ingelheim

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Medication product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Medication, with revenue, gross margin and global market share of Medication from 2019 to 2022.

Chapter 3, the Medication competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Medication market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Medication research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Medication

1.2 Classification of Medication by Type

1.2.1 Overview: Global Medication Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Medication Revenue Market Share by Type in 2021

1.2.3 Brand Drugs

1.2.4 Generic Drug

1.3 Global Medication Market by Application

1.3.1 Overview: Global Medication Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Medication Market Size & Forecast

1.5 Global Medication Market Size and Forecast by Region

1.5.1 Global Medication Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Medication Market Size by Region, (2017-2022)

1.5.3 North America Medication Market Size and Prospect (2017-2028)

1.5.4 Europe Medication Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Medication Market Size and Prospect (2017-2028)

1.5.6 South America Medication Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Medication Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Medication Market Drivers

1.6.2 Medication Market Restraints

1.6.3 Medication Trends Analysis

2 Company Profiles

2.1 Pfizer

2.1.1 Pfizer Details

2.1.2 Pfizer Major Business

2.1.3 Pfizer Medication Product and Solutions

2.1.4 Pfizer Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Pfizer Recent Developments and Future Plans

2.2 Roche

2.2.1 Roche Details

2.2.2 Roche Major Business

2.2.3 Roche Medication Product and Solutions

2.2.4 Roche Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Roche Recent Developments and Future Plans

2.3 Sanofi

2.3.1 Sanofi Details

2.3.2 Sanofi Major Business

2.3.3 Sanofi Medication Product and Solutions

2.3.4 Sanofi Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Sanofi Recent Developments and Future Plans

2.4 Johnson & Johnson

2.4.1 Johnson & Johnson Details

2.4.2 Johnson & Johnson Major Business

2.4.3 Johnson & Johnson Medication Product and Solutions

2.4.4 Johnson & Johnson Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Johnson & Johnson Recent Developments and Future Plans

2.5 Merck & Co. (MSD)

2.5.1 Merck & Co. (MSD) Details

2.5.2 Merck & Co. (MSD) Major Business

2.5.3 Merck & Co. (MSD) Medication Product and Solutions

2.5.4 Merck & Co. (MSD) Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Merck & Co. (MSD) Recent Developments and Future Plans

2.6 Novartis

2.6.1 Novartis Details

2.6.2 Novartis Major Business

2.6.3 Novartis Medication Product and Solutions

2.6.4 Novartis Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Novartis Recent Developments and Future Plans

2.7 AbbVie

2.7.1 AbbVie Details

2.7.2 AbbVie Major Business

2.7.3 AbbVie Medication Product and Solutions

2.7.4 AbbVie Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 AbbVie Recent Developments and Future Plans

2.8 Gilead Sciences

2.8.1 Gilead Sciences Details

2.8.2 Gilead Sciences Major Business

2.8.3 Gilead Sciences Medication Product and Solutions

2.8.4 Gilead Sciences Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Gilead Sciences Recent Developments and Future Plans

2.9 GlaxoSmithKline (GSK)

2.9.1 GlaxoSmithKline (GSK) Details

2.9.2 GlaxoSmithKline (GSK) Major Business

2.9.3 GlaxoSmithKline (GSK) Medication Product and Solutions

2.9.4 GlaxoSmithKline (GSK) Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 GlaxoSmithKline (GSK) Recent Developments and Future Plans

2.10 Amgen

2.10.1 Amgen Details

2.10.2 Amgen Major Business

2.10.3 Amgen Medication Product and Solutions

2.10.4 Amgen Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Amgen Recent Developments and Future Plans

2.11 AstraZeneca

2.11.1 AstraZeneca Details

2.11.2 AstraZeneca Major Business

2.11.3 AstraZeneca Medication Product and Solutions

2.11.4 AstraZeneca Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 AstraZeneca Recent Developments and Future Plans

2.12 Bristol-Myers Squibb

2.12.1 Bristol-Myers Squibb Details

2.12.2 Bristol-Myers Squibb Major Business

2.12.3 Bristol-Myers Squibb Medication Product and Solutions

2.12.4 Bristol-Myers Squibb Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Bristol-Myers Squibb Recent Developments and Future Plans

2.13 Eli Lilly

2.13.1 Eli Lilly Details

2.13.2 Eli Lilly Major Business

2.13.3 Eli Lilly Medication Product and Solutions

2.13.4 Eli Lilly Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Eli Lilly Recent Developments and Future Plans

2.14 Teva

2.14.1 Teva Details

2.14.2 Teva Major Business

2.14.3 Teva Medication Product and Solutions

2.14.4 Teva Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Teva Recent Developments and Future Plans

2.15 Bayer

2.15.1 Bayer Details

2.15.2 Bayer Major Business

2.15.3 Bayer Medication Product and Solutions

2.15.4 Bayer Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Bayer Recent Developments and Future Plans

2.16 Novo Nordisk

2.16.1 Novo Nordisk Details

2.16.2 Novo Nordisk Major Business

2.16.3 Novo Nordisk Medication Product and Solutions

2.16.4 Novo Nordisk Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 Novo Nordisk Recent Developments and Future Plans

2.17 Allergan

2.17.1 Allergan Details

2.17.2 Allergan Major Business

2.17.3 Allergan Medication Product and Solutions

2.17.4 Allergan Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 Allergan Recent Developments and Future Plans

2.18 Takeda

2.18.1 Takeda Details

2.18.2 Takeda Major Business

2.18.3 Takeda Medication Product and Solutions

2.18.4 Takeda Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.18.5 Takeda Recent Developments and Future Plans

2.19 Boehringer Ingelheim

2.19.1 Boehringer Ingelheim Details

2.19.2 Boehringer Ingelheim Major Business

2.19.3 Boehringer Ingelheim Medication Product and Solutions

2.19.4 Boehringer Ingelheim Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.19.5 Boehringer Ingelheim Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Medication Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Medication Players Market Share in 2021

3.2.2 Top 10 Medication Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Medication Players Head Office, Products and Services Provided

3.4 Medication Mergers & Acquisitions

3.5 Medication New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Medication Revenue and Market Share by Type (2017-2022)

4.2 Global Medication Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Medication Revenue Market Share by Application (2017-2022)

5.2 Global Medication Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Medication Revenue by Type (2017-2028)

6.2 North America Medication Revenue by Application (2017-2028)

6.3 North America Medication Market Size by Country

6.3.1 North America Medication Revenue by Country (2017-2028)

6.3.2 United States Medication Market Size and Forecast (2017-2028)

6.3.3 Canada Medication Market Size and Forecast (2017-2028)

6.3.4 Mexico Medication Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Medication Revenue by Type (2017-2028)

7.2 Europe Medication Revenue by Application (2017-2028)

7.3 Europe Medication Market Size by Country

7.3.1 Europe Medication Revenue by Country (2017-2028)

7.3.2 Germany Medication Market Size and Forecast (2017-2028)

7.3.3 France Medication Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Medication Market Size and Forecast (2017-2028)

7.3.5 Russia Medication Market Size and Forecast (2017-2028)

7.3.6 Italy Medication Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Medication Revenue by Type (2017-2028)

8.2 Asia-Pacific Medication Revenue by Application (2017-2028)

8.3 Asia-Pacific Medication Market Size by Region

8.3.1 Asia-Pacific Medication Revenue by Region (2017-2028)

8.3.2 China Medication Market Size and Forecast (2017-2028)

8.3.3 Japan Medication Market Size and Forecast (2017-2028)

8.3.4 South Korea Medication Market Size and Forecast (2017-2028)

8.3.5 India Medication Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Medication Market Size and Forecast (2017-2028)

8.3.7 Australia Medication Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Medication Revenue by Type (2017-2028)

9.2 South America Medication Revenue by Application (2017-2028)

9.3 South America Medication Market Size by Country

9.3.1 South America Medication Revenue by Country (2017-2028)

9.3.2 Brazil Medication Market Size and Forecast (2017-2028)

9.3.3 Argentina Medication Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Medication Revenue by Type (2017-2028)

10.2 Middle East & Africa Medication Revenue by Application (2017-2028)

10.3 Middle East & Africa Medication Market Size by Country

10.3.1 Middle East & Africa Medication Revenue by Country (2017-2028)

10.3.2 Turkey Medication Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Medication Market Size and Forecast (2017-2028)

10.3.4 UAE Medication Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Medication Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Medication Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Medication Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Medication Revenue (USD Million) by Region (2017-2022)

Table 5. Global Medication Revenue Market Share by Region (2023-2028)

Table 6. Pfizer Corporate Information, Head Office, and Major Competitors

Table 7. Pfizer Major Business

Table 8. Pfizer Medication Product and Solutions

Table 9. Pfizer Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Roche Corporate Information, Head Office, and Major Competitors

Table 11. Roche Major Business

Table 12. Roche Medication Product and Solutions

Table 13. Roche Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Sanofi Corporate Information, Head Office, and Major Competitors

Table 15. Sanofi Major Business

Table 16. Sanofi Medication Product and Solutions

Table 17. Sanofi Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 19. Johnson & Johnson Major Business

Table 20. Johnson & Johnson Medication Product and Solutions

Table 21. Johnson & Johnson Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Merck & Co. (MSD) Corporate Information, Head Office, and Major Competitors

Table 23. Merck & Co. (MSD) Major Business

Table 24. Merck & Co. (MSD) Medication Product and Solutions

Table 25. Merck & Co. (MSD) Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Novartis Corporate Information, Head Office, and Major Competitors

Table 27. Novartis Major Business

Table 28. Novartis Medication Product and Solutions

Table 29. Novartis Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. AbbVie Corporate Information, Head Office, and Major Competitors

Table 31. AbbVie Major Business

Table 32. AbbVie Medication Product and Solutions

Table 33. AbbVie Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Gilead Sciences Corporate Information, Head Office, and Major Competitors

Table 35. Gilead Sciences Major Business

Table 36. Gilead Sciences Medication Product and Solutions

Table 37. Gilead Sciences Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. GlaxoSmithKline (GSK) Corporate Information, Head Office, and Major Competitors

Table 39. GlaxoSmithKline (GSK) Major Business

Table 40. GlaxoSmithKline (GSK) Medication Product and Solutions

Table 41. GlaxoSmithKline (GSK) Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Amgen Corporate Information, Head Office, and Major Competitors

Table 43. Amgen Major Business

Table 44. Amgen Medication Product and Solutions

Table 45. Amgen Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. AstraZeneca Corporate Information, Head Office, and Major Competitors

Table 47. AstraZeneca Major Business

Table 48. AstraZeneca Medication Product and Solutions

Table 49. AstraZeneca Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors

Table 51. Bristol-Myers Squibb Major Business

Table 52. Bristol-Myers Squibb Medication Product and Solutions

Table 53. Bristol-Myers Squibb Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Eli Lilly Corporate Information, Head Office, and Major Competitors

Table 55. Eli Lilly Major Business

Table 56. Eli Lilly Medication Product and Solutions

Table 57. Eli Lilly Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Teva Corporate Information, Head Office, and Major Competitors

Table 59. Teva Major Business

Table 60. Teva Medication Product and Solutions

Table 61. Teva Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Bayer Corporate Information, Head Office, and Major Competitors

Table 63. Bayer Major Business

Table 64. Bayer Medication Product and Solutions

Table 65. Bayer Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Novo Nordisk Corporate Information, Head Office, and Major Competitors

Table 67. Novo Nordisk Major Business

Table 68. Novo Nordisk Medication Product and Solutions

Table 69. Novo Nordisk Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. Allergan Corporate Information, Head Office, and Major Competitors

Table 71. Allergan Major Business

Table 72. Allergan Medication Product and Solutions

Table 73. Allergan Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. Takeda Corporate Information, Head Office, and Major Competitors

Table 75. Takeda Major Business

Table 76. Takeda Medication Product and Solutions

Table 77. Takeda Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 78. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors

Table 79. Boehringer Ingelheim Major Business

Table 80. Boehringer Ingelheim Medication Product and Solutions

Table 81. Boehringer Ingelheim Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 82. Global Medication Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 83. Global Medication Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 84. Breakdown of Medication by Company Type (Tier 1, Tier 2 and Tier 3)

Table 85. Medication Players Head Office, Products and Services Provided

Table 86. Medication Mergers & Acquisitions in the Past Five Years

Table 87. Medication New Entrants and Expansion Plans

Table 88. Global Medication Revenue (USD Million) by Type (2017-2022)

Table 89. Global Medication Revenue Share by Type (2017-2022)

Table 90. Global Medication Revenue Forecast by Type (2023-2028)

Table 91. Global Medication Revenue by Application (2017-2022)

Table 92. Global Medication Revenue Forecast by Application (2023-2028)

Table 93. North America Medication Revenue by Type (2017-2022) & (USD Million)

Table 94. North America Medication Revenue by Type (2023-2028) & (USD Million)

Table 95. North America Medication Revenue by Application (2017-2022) & (USD Million)

Table 96. North America Medication Revenue by Application (2023-2028) & (USD Million)

Table 97. North America Medication Revenue by Country (2017-2022) & (USD Million)

Table 98. North America Medication Revenue by Country (2023-2028) & (USD Million)

Table 99. Europe Medication Revenue by Type (2017-2022) & (USD Million)

Table 100. Europe Medication Revenue by Type (2023-2028) & (USD Million)

Table 101. Europe Medication Revenue by Application (2017-2022) & (USD Million)

Table 102. Europe Medication Revenue by Application (2023-2028) & (USD Million)

Table 103. Europe Medication Revenue by Country (2017-2022) & (USD Million)

Table 104. Europe Medication Revenue by Country (2023-2028) & (USD Million)

Table 105. Asia-Pacific Medication Revenue by Type (2017-2022) & (USD Million)

Table 106. Asia-Pacific Medication Revenue by Type (2023-2028) & (USD Million)

Table 107. Asia-Pacific Medication Revenue by Application (2017-2022) & (USD Million)

Table 108. Asia-Pacific Medication Revenue by Application (2023-2028) & (USD Million)

Table 109. Asia-Pacific Medication Revenue by Region (2017-2022) & (USD Million)

Table 110. Asia-Pacific Medication Revenue by Region (2023-2028) & (USD Million)

Table 111. South America Medication Revenue by Type (2017-2022) & (USD Million)

Table 112. South America Medication Revenue by Type (2023-2028) & (USD Million)

Table 113. South America Medication Revenue by Application (2017-2022) & (USD Million)

Table 114. South America Medication Revenue by Application (2023-2028) & (USD Million)

Table 115. South America Medication Revenue by Country (2017-2022) & (USD Million)

Table 116. South America Medication Revenue by Country (2023-2028) & (USD Million)

Table 117. Middle East & Africa Medication Revenue by Type (2017-2022) & (USD Million)

Table 118. Middle East & Africa Medication Revenue by Type (2023-2028) & (USD Million)

Table 119. Middle East & Africa Medication Revenue by Application (2017-2022) & (USD Million)

Table 120. Middle East & Africa Medication Revenue by Application (2023-2028) & (USD Million)

Table 121. Middle East & Africa Medication Revenue by Country (2017-2022) & (USD Million)

Table 122. Middle East & Africa Medication Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Medication Picture

Figure 2. Global Medication Revenue Market Share by Type in 2021

Figure 3. Brand Drugs

Figure 4. Generic Drug

Figure 5. Medication Revenue Market Share by Application in 2021

Figure 6. Hospital Picture

Figure 7. Clinic Picture

Figure 8. Other Picture

Figure 9. Global Medication Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 10. Global Medication Revenue and Forecast (2017-2028) & (USD Million)

Figure 11. Global Medication Revenue Market Share by Region (2017-2028)

Figure 12. Global Medication Revenue Market Share by Region in 2021

Figure 13. North America Medication Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Europe Medication Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Asia-Pacific Medication Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. South America Medication Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Middle East and Africa Medication Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Medication Market Drivers

Figure 19. Medication Market Restraints

Figure 20. Medication Market Trends

Figure 21. Pfizer Recent Developments and Future Plans

Figure 22. Roche Recent Developments and Future Plans

Figure 23. Sanofi Recent Developments and Future Plans

Figure 24. Johnson & Johnson Recent Developments and Future Plans

Figure 25. Merck & Co. (MSD) Recent Developments and Future Plans

Figure 26. Novartis Recent Developments and Future Plans

Figure 27. AbbVie Recent Developments and Future Plans

Figure 28. Gilead Sciences Recent Developments and Future Plans

Figure 29. GlaxoSmithKline (GSK) Recent Developments and Future Plans

Figure 30. Amgen Recent Developments and Future Plans

Figure 31. AstraZeneca Recent Developments and Future Plans

Figure 32. Bristol-Myers Squibb Recent Developments and Future Plans

Figure 33. Eli Lilly Recent Developments and Future Plans

Figure 34. Teva Recent Developments and Future Plans

Figure 35. Bayer Recent Developments and Future Plans

Figure 36. Novo Nordisk Recent Developments and Future Plans

Figure 37. Allergan Recent Developments and Future Plans

Figure 38. Takeda Recent Developments and Future Plans

Figure 39. Boehringer Ingelheim Recent Developments and Future Plans

Figure 40. Global Medication Revenue Share by Players in 2021

Figure 41. Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 42. Global Top 3 Players Medication Revenue Market Share in 2021

Figure 43. Global Top 10 Players Medication Revenue Market Share in 2021

Figure 44. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 45. Global Medication Revenue Share by Type in 2021

Figure 46. Global Medication Market Share Forecast by Type (2023-2028)

Figure 47. Global Medication Revenue Share by Application in 2021

Figure 48. Global Medication Market Share Forecast by Application (2023-2028)

Figure 49. North America Medication Sales Market Share by Type (2017-2028)

Figure 50. North America Medication Sales Market Share by Application (2017-2028)

Figure 51. North America Medication Revenue Market Share by Country (2017-2028)

Figure 52. United States Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Canada Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Mexico Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Europe Medication Sales Market Share by Type (2017-2028)

Figure 56. Europe Medication Sales Market Share by Application (2017-2028)

Figure 57. Europe Medication Revenue Market Share by Country (2017-2028)

Figure 58. Germany Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. France Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. United Kingdom Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Russia Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Italy Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Asia-Pacific Medication Sales Market Share by Type (2017-2028)

Figure 64. Asia-Pacific Medication Sales Market Share by Application (2017-2028)

Figure 65. Asia-Pacific Medication Revenue Market Share by Region (2017-2028)

Figure 66. China Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Japan Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. South Korea Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. India Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Southeast Asia Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Australia Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. South America Medication Sales Market Share by Type (2017-2028)

Figure 73. South America Medication Sales Market Share by Application (2017-2028)

Figure 74. South America Medication Revenue Market Share by Country (2017-2028)

Figure 75. Brazil Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Argentina Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Middle East and Africa Medication Sales Market Share by Type (2017-2028)

Figure 78. Middle East and Africa Medication Sales Market Share by Application (2017-2028)

Figure 79. Middle East and Africa Medication Revenue Market Share by Country (2017-2028)

Figure 80. Turkey Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. Saudi Arabia Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. UAE Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 83. Methodology

Figure 84. Research Process and Data Source